These findings suggest that, as a major haploinsufficient tumor suppressor gene, PinX1 expression was correlated to the risk of PCa progression and may serve as a potential marker for the diagnosis of PCa patients. The gene discussed is PINX1; the disease is posterior cortical atrophy.